Calamos Advisors LLC Has $4.41 Million Stake in Millicom International Cellular SA $TIGO

Key Points

• Calamos Advisors cut its stake in Millicom by 26.5%, selling 28,680 shares to hold 79,550 shares valued at about $4.41 million as of its latest SEC filing.
• Other institutions grew positions sharply—most notably JPMorgan Chase, which increased holdings by 348.9% to 6,459,716 shares (≈$313.6 million), while Barclays, State Street, Northern Trust and Goldman also added exposure.
• Millicom reported a strong quarter with EPS $1.50 vs. $1.05 expected and revenue of $1.65 billion (up 15.7% year-over-year), and announced a $0.75 quarterly dividend (3.6% yield) with an ex-dividend date of April 8.

Calamos Advisors LLC reduced its holdings in Millicom International Cellular SA (NASDAQ:TIGO - Free Report) by 26.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 79,550 shares of the technology company's stock after selling 28,680 shares during the quarter. Calamos Advisors LLC's holdings in Millicom International Cellular were worth $4,410,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in TIGO. JPMorgan Chase & Co. grew its holdings in Millicom International Cellular by 348.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 6,459,716 shares of the technology company's stock valued at $313,555,000 after buying an additional 5,020,602 shares during the last quarter. Barclays PLC increased its position in Millicom International Cellular by 1.7% during the third quarter. Barclays PLC now owns 2,895,215 shares of the technology company's stock worth $140,534,000 after acquiring an additional 47,194 shares during the period. State Street Corp raised its stake in Millicom International Cellular by 129.2% during the 2nd quarter. State Street Corp now owns 1,820,070 shares of the technology company's stock valued at $68,198,000 after purchasing an additional 1,026,063 shares during the last quarter. Goldman Sachs Group Inc. bought a new stake in Millicom International Cellular in the 1st quarter valued at $50,664,000. Finally, Northern Trust Corp grew its position in Millicom International Cellular by 128.2% in the 3rd quarter. Northern Trust Corp now owns 1,271,086 shares of the technology company's stock worth $61,699,000 after purchasing an additional 714,158 shares during the last quarter.

Millicom International Cellular Price Performance

NASDAQ TIGO opened at $84.06 on Monday. Millicom International Cellular SA has a 1-year low of $30.26 and a 1-year high of $85.05. The company has a market capitalization of $14.21 billion, a price-to-earnings ratio of 10.71 and a beta of 0.87. The stock's 50 day moving average is $74.91 and its two-hundred day moving average is $61.19. The company has a current ratio of 0.88, a quick ratio of 0.86 and a debt-to-equity ratio of 1.81.

Millicom International Cellular (NASDAQ:TIGO - Get Free Report) last issued its earnings results on Thursday, February 26th. The technology company reported $1.50 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.05 by $0.45. The business had revenue of $1.65 billion during the quarter, compared to analysts' expectations of $1.49 billion. Millicom International Cellular had a return on equity of 17.07% and a net margin of 22.62%.Millicom International Cellular's quarterly revenue was up 15.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.18 EPS. Equities analysts forecast that Millicom International Cellular SA will post 3.23 earnings per share for the current fiscal year.

Millicom International Cellular Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 15th. Shareholders of record on Thursday, April 8th will be paid a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 3.6%. The ex-dividend date is Thursday, April 8th. Millicom International Cellular's dividend payout ratio is currently 38.22%.

Analyst Ratings Changes

A number of research analysts have recently commented on TIGO shares. Weiss Ratings reaffirmed a "buy (b)" rating on shares of Millicom International Cellular in a research report on Thursday, January 22nd. Zacks Research upgraded Millicom International Cellular from a "strong sell" rating to a "hold" rating in a research note on Monday, April 6th. Wall Street Zen cut Millicom International Cellular from a "strong-buy" rating to a "buy" rating in a report on Saturday, March 28th. Scotiabank raised their price objective on Millicom International Cellular from $43.00 to $51.20 and gave the stock a "sector underperform" rating in a research report on Monday, March 30th. Finally, HSBC raised Millicom International Cellular from a "hold" rating to a "buy" rating and set a $89.00 price objective on the stock in a report on Friday, March 6th. Five research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $65.64.

Millicom International Cellular Profile

Millicom International Cellular SA, trading under the TIGO brand, is a Luxembourg‐headquartered telecommunications and media company that provides a range of mobile, cable broadband, digital television and enterprise services. Through its integrated infrastructure, the company delivers voice and data connectivity, high‐speed internet access and pay‐television packages to millions of customers, supported by ongoing investments in network coverage and capacity.

Established in 1990 by Swedish investor Jan Stenbeck, Millicom has grown into a multi‐regional operator focused primarily on Central and South America.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.